Being tested
Assistive and other devices: improve symptoms or function in MS (type not specified)
MS (type not specified) · Assistive and other devices
Trials are running now and no controlled trial has a readable result yet.
- Trials
- 34
- Running now
- 9
- Controlled phase 2/3 trials
- 0
- People in controlled trials
- 0
How the verdict was reached
Phase 3 results not all read yet
| Trial | Phase | Participants | Started | Result | Counted |
|---|---|---|---|---|---|
| Device other, trial | Not a drug-phase study | 30 | 2004 | Paper found, not read | Not counted: not randomised |
| Interferon beta-1a, phase 3 | Phase 3 | 74 | 2005 | No results found | Not counted: not randomised |
| CIBI | Phase 3 | 0 | 2010 | Stopped | Not counted: not randomised |
| SAMSPAP | Not a drug-phase study | 49 | 2013 | Paper found, not read | Not counted: phase 1 or phase 4 |
| Device other, trial | Not a drug-phase study | 30 | 2013 | No results found | Not counted: not randomised |
| Device other, trial | Not a drug-phase study | 2 | 2013 | No results found | Not counted: not randomised |
| Device other, trial | Not a drug-phase study | 100 | 2015 | No results found | Not counted: not randomised |
| Device other, trial | Not a drug-phase study | 10 | 2014 | No results found | Not counted: not randomised |
| Device other, trial | Not a drug-phase study | 5 | 2015 | No results found | Not counted: not randomised |
| Device other, trial | Not a drug-phase study | 135 | 2015 | No results found | Not counted: not randomised |
| Device other, trial | Not a drug-phase study | 5 | 2015 | No results found | Not counted: phase 1 or phase 4 |
| Device other, trial | Not a drug-phase study | 60 | 2016 | No results found | Not counted: phase 1 or phase 4 |
| Device other, trial | Not a drug-phase study | 20 | 2016 | No results found | Not counted: phase 1 or phase 4 |
| Device other, trial | Not a drug-phase study | 30 | 2017 | No results found | Not counted: not randomised |
| Device other, trial | Not a drug-phase study | 85 | 2019 | No results found | Not counted: not randomised |
| Device other, trial | Not a drug-phase study | 92 | 2020 | Paper found, not read | Not counted: not randomised |
| NEUROSTIM-SEP1 | Not a drug-phase study | 68 | 2021 | Still running | Not counted: phase 1 or phase 4 |
| Device other, trial | Not a drug-phase study | 36 | 2019 | No results found | Not counted: phase 1 or phase 4 |
| FlowOx-MS | Not a drug-phase study | 10 | 2021 | No results found | Not counted: not randomised |
| MonSter | Not a drug-phase study | 208 | 2021 | Paper found, not read | Not counted: not randomised |
| Device other, trial | Not a drug-phase study | 56 | 2022 | Paper found, not read | Not counted: phase 1 or phase 4 |
| Device other, trial | Not a drug-phase study | 58 | 2022 | No results found | Not counted: not randomised |
| WeB | Not a drug-phase study | 20 | 2023 | Still running | Not counted: not randomised |
| FETEM | Phase 3 | 144 | 2022 | Paper found, not read | Counts only if it beats amantadine |
| Cubii | Not a drug-phase study | 21 | 2023 | Missed its main goal | Not counted: not randomised |
| Device other, trial | Not a drug-phase study | 44 | 2023 | No results found | Not counted: phase 1 or phase 4 |
| Device other, trial | Not a drug-phase study | 24 | 2024 | Still running | Not counted: phase 1 or phase 4 |
| MUSIBOT | Not a drug-phase study | 80 | 2025 | Still running | Not counted: not randomised |
| Device other, trial | Not a drug-phase study | 75 | 2025 | No results found | Not counted: not randomised |
| NS-BOOSST | Not a drug-phase study | 34 | 2025 | Still running | Not counted: not randomised |
| Device other, phase 4 | Phase 4 | 100 | 2026 | Still running | Not counted: not randomised |
| EXO-MOBILITY | Not a drug-phase study | 77 | 2026 | Still running | Not counted: phase 1 or phase 4 |
| Device other, trial | Not a drug-phase study | 90 | 2026 | Still running | Not counted: not randomised |
| Device other, trial | Not a drug-phase study | 60 | 2026 | Still running | Not counted: not randomised |
Counted: 0. Will count later: 1. Not counted: 33.
Lab evidence
Lab studies in animals or cells. Results in animals often do not hold in people, and these studies never change the status of an idea.
Loading lab studies…
Loading reviews and guidelines…
History
- Nov 2026Trials: 36 → 34
- Oct 2026Trials: 43 → 36
- Oct 2026Trials: 42 → 43
- Oct 2026First listed as Being tested
Related hypotheses
- Assistive and other devices: improve symptoms or function in NMOSD
- Assistive and other devices: improve symptoms or function in primary progressive MS
- Assistive and other devices: improve symptoms or function in relapsing MS
- Assistive and other devices: improve symptoms or function in relapsing and progressive MS
Assembled by software from public sources.